Articles Tagged with ''FDA''

In an effort to allow FDA to sample water, soil and environmental conditions on USDA-regulated concentrated animal feeding operations (CAFOs), New York Sen. Kirsten E. Gillibrand introduced a bill that would provide the FDA authority to conduct microbial sampling on CAFOs as necessary for a foodborne illness outbreak investigation, determine the outbreak’s root cause or address other public health needs.

The FDA has issued final guidance to help manufacturers of packaged foods comply with the updated Nutrition Facts labeling regulations, which addresses serving sizes of foods, including single-serving foods and other foods that can reasonably be consumed at one eating occasion and require dual-column labeling.

As the seven foundational rules of FSMA reach their compliance dates, the FDA has begun to track their impact on the food safety system.

New chapters and sections of the Fish and Fishery Products Hazards and Controls Guidance, including the updated 21 CFR Part 123—Fish and Fishery Products, were updated by the FDA in August.

The FDA recently held a hearing designed to include information and views related to the safety of cannabis edibles and beverages—with a strong emphasis on cannabidiol (CBD) ingredients—as well as to solicit input relevant to the agency's regulatory strategy for existing products.

Many processors have grown more sophisticated at compiling information and presenting it when inspectors ask for proof that a facility's food safety management system is working. But no matter the companies’ size or record management methods, they likely experience some of the common deficiencies that experts see.

FDA intends to exercise this enforcement discretion to provide industry with greater flexibility when labeling food products, including those formulated to reduce sodium content.

The FDA held a public hearing on May 31 to solicit oral presentations and comments in order to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived products.

USDA's FSIS and FDA released a formal agreement to address the regulatory oversight of human food products derived from the cells of livestock and poultry, which describes the oversight roles and responsibilities for both agencies and how they will collaborate to regulate the development and entry of these products into commerce.